What’s next for GLP-1 weight loss drugs?

GLP-1 Receptor Agonists Slow Epigenetic Aging, a Measure of the Harms Done by Excess Visceral Fat

Weight loss drugs are a major focus of the pharmaceutical industry at present. It remains to be seen as to what will emerge as the next big class of weight loss drugs following GLP-1 receptor agonists. Since the primary…